Conduct a quiz for me BCQs pharmacology ,,, antiphycosis , antianxyoloytic ,,, anti depressants with thier MAOs and from lipponcott and ketzung

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have enough material from both Lippincott and Katzung to build a thorough, accurate quiz. Let me compile it.

🧠 Pharmacology MCQ Quiz

Antipsychotics | Anxiolytics | Antidepressants (MAO included)

Sources: Lippincott Illustrated Reviews Pharmacology & Katzung's Basic and Clinical Pharmacology, 16th Ed.

Instructions: Choose the single best answer. Answers + explanations are at the bottom. Good luck!

SECTION A: ANTIPSYCHOTICS (10 Questions)

Q1. A patient with schizophrenia develops a parkinsonian tremor, rigidity, and bradykinesia after starting a medication. Which receptor blockade is MOST responsible for these extrapyramidal side effects?

A) Muscarinic M1 receptors
B) Histamine H1 receptors
C) Dopamine D2 receptors in the nigrostriatal pathway
D) Serotonin 5-HT2A receptors
E) Alpha-1 adrenergic receptors

Q2. Which first-generation (typical) antipsychotic is classified as LOW potency and is most associated with sedation and orthostatic hypotension rather than extrapyramidal symptoms?

A) Haloperidol
B) Fluphenazine
C) Chlorpromazine
D) Trifluoperazine
E) Perphenazine

Q3. Clozapine is reserved for treatment-resistant schizophrenia. Which potentially FATAL adverse effect requires mandatory weekly/biweekly CBC monitoring?

A) Tardive dyskinesia
B) Agranulocytosis
C) Neuroleptic malignant syndrome
D) QT prolongation
E) Metabolic syndrome

Q4. A 30-year-old patient on haloperidol develops fever (40°C), severe muscle rigidity, altered consciousness, and elevated CK. What is the MOST likely diagnosis?

A) Tardive dyskinesia
B) Acute dystonia
C) Serotonin syndrome
D) Neuroleptic malignant syndrome (NMS)
E) Malignant hyperthermia

Q5. Which SECOND-generation (atypical) antipsychotic is a PARTIAL AGONIST at D2 and 5-HT1A receptors AND an ANTAGONIST at 5-HT2A receptors?

A) Risperidone
B) Olanzapine
C) Quetiapine
D) Aripiprazole
E) Clozapine

Q6. According to Lippincott, the POSITIVE symptoms of schizophrenia (hallucinations, delusions) are linked to hyperdopaminergic dysfunction in which pathway?

A) Nigrostriatal pathway
B) Mesolimbic pathway
C) Mesocortical pathway
D) Tuberoinfundibular pathway
E) Hypothalamic pathway

Q7. Hyperprolactinemia causing galactorrhea and amenorrhea is a side effect of antipsychotics due to dopamine blockade in which tract?

A) Nigrostriatal
B) Mesolimbic
C) Mesocortical
D) Tuberoinfundibular
E) Spinocerebellar

Q8. Which atypical antipsychotic has the HIGHEST risk of metabolic syndrome (weight gain, dyslipidemia, hyperglycemia)?

A) Aripiprazole
B) Ziprasidone
C) Risperidone
D) Olanzapine
E) Lurasidone

Q9. A patient on an antipsychotic develops involuntary, repetitive, purposeless movements of the tongue and face after 2 years of therapy. This is MOST consistent with:

A) Acute dystonia
B) Akathisia
C) Tardive dyskinesia
D) Pseudoparkinsonism
E) Neuroleptic malignant syndrome

Q10. Pimavanserin, used in Parkinson's disease psychosis, works WITHOUT causing motor worsening. What is its mechanism?

A) D2 receptor antagonism
B) D1 receptor agonism
C) 5-HT2A/2C inverse agonist (no D2 blockade)
D) Muscarinic antagonism
E) Glutamate NMDA modulation

SECTION B: ANXIOLYTICS (8 Questions)

Q11. Benzodiazepines produce their anxiolytic effect by binding to which site on the GABA-A receptor?

A) The GABA binding site directly
B) A separate allosteric site, increasing frequency of Cl⁻ channel opening
C) A separate allosteric site, increasing duration of Cl⁻ channel opening
D) Voltage-gated Na⁺ channels
E) Glycine receptors

Q12. A patient requires an anxiolytic but has severe liver disease. Which benzodiazepine is SAFEST because it undergoes glucuronidation only (no Phase I hepatic metabolism)?

A) Diazepam
B) Chlordiazepoxide
C) Alprazolam
D) Lorazepam
E) Midazolam

(Hint: "LOT" - Lorazepam, Oxazepam, Temazepam)

Q13. Flumazenil is used to reverse benzodiazepine overdose. What is its mechanism?

A) GABA-A agonist
B) GABA-A competitive antagonist at the benzodiazepine binding site
C) Increases GABA release
D) Inhibits GABA-T enzyme
E) Opioid receptor antagonist

Q14. Buspirone is used for generalized anxiety disorder (GAD). Unlike benzodiazepines, which statement is TRUE about buspirone?

A) It causes significant sedation
B) It has high abuse potential
C) Its effect is immediate (within hours)
D) It is a 5-HT1A partial agonist with no physical dependence
E) It enhances GABA at Cl⁻ channels

Q15. Barbiturates differ from benzodiazepines at the GABA-A receptor in that barbiturates:

A) Increase frequency of Cl⁻ channel opening
B) Increase duration of Cl⁻ channel opening
C) Act at the benzodiazepine binding site
D) Are reversed by flumazenil
E) Have a high therapeutic index

Q16. Which of the following benzodiazepines has the LONGEST half-life and active metabolites, making it useful for alcohol withdrawal but risky in elderly patients?

A) Triazolam
B) Lorazepam
C) Oxazepam
D) Diazepam
E) Midazolam

Q17. A patient taking a benzodiazepine for 6 months is abruptly stopped. Which symptom would be MOST expected?

A) Bradycardia and hypotension
B) Rebound anxiety, insomnia, and seizures
C) Respiratory depression and coma
D) Hyperthermia and metabolic acidosis
E) Agranulocytosis

Q18. According to Lippincott, which drug class is ALSO indicated for anxiety disorders (e.g., GAD, PTSD, panic disorder) and is discussed separately under antidepressants?

A) Barbiturates
B) Antihistamines
C) Antidepressants (SSRIs/SNRIs)
D) Beta-blockers
E) Meprobamate

SECTION C: ANTIDEPRESSANTS + MAOIs (12 Questions)

Q19. According to Lippincott's biogenic amine theory, depression is due to:

A) Excess norepinephrine and serotonin at synapses
B) Deficiency of monoamines (norepinephrine and serotonin) at key brain sites
C) Excess acetylcholine
D) Deficiency of dopamine in the mesolimbic tract
E) Excess glutamate at NMDA receptors

Q20. SSRIs block the serotonin transporter (SERT). Which SSRI has the LONGEST half-life (~1-4 days for parent drug, ~1-2 weeks for active metabolite norfluoxetine), making it safest in the event of missed doses?

A) Sertraline
B) Paroxetine
C) Fluoxetine
D) Citalopram
E) Fluvoxamine

Q21. A patient on fluoxetine is started on tramadol. Which DANGEROUS interaction should the prescriber be MOST concerned about?

A) Neuroleptic malignant syndrome
B) Serotonin syndrome
C) Hypertensive crisis
D) Anticholinergic toxidrome
E) QT prolongation

Q22. TCAs (tricyclic antidepressants) inhibit the reuptake of which two neurotransmitters?

A) Dopamine and serotonin
B) Norepinephrine and serotonin
C) GABA and glutamate
D) Acetylcholine and histamine
E) Norepinephrine and dopamine

Q23. TCA overdose is life-threatening. The CLASSIC triad in TCA overdose is:

A) Hyperthermia + rigidity + altered mental status
B) Miosis + bradycardia + respiratory depression
C) Sedation + arrhythmia + anticholinergic symptoms (wide QRS)
D) Diarrhea + diaphoresis + clonus
E) Seizures + metabolic acidosis + renal failure

Q24. Phenelzine and tranylcypromine are irreversible, NON-SELECTIVE MAO inhibitors. A patient on phenelzine eats aged cheese (rich in tyramine). What reaction occurs?

A) Hypotensive crisis
B) Serotonin syndrome
C) Hypertensive crisis ("cheese reaction")
D) Anticholinergic toxidrome
E) Opioid overdose picture

Q25. Selegiline at LOW doses (used in Parkinson's disease) is a SELECTIVE inhibitor of which MAO isoform?

A) MAO-A
B) MAO-B
C) Both MAO-A and MAO-B equally
D) Catechol-O-methyltransferase (COMT)
E) Aldehyde dehydrogenase

Q26. Bupropion is an atypical antidepressant also approved for smoking cessation. Its mechanism is:

A) SSRI
B) 5-HT2A antagonist + SSRI
C) Norepinephrine-dopamine reuptake inhibitor (NDRI)
D) 5-HT1A partial agonist
E) Monoamine oxidase inhibitor

Q27. Mirtazapine's unique mechanism involves:

A) Serotonin reuptake inhibition
B) Alpha-2 adrenergic presynaptic ANTAGONISM, increasing release of NE and 5-HT, plus 5-HT2/5-HT3 blockade
C) Dopamine reuptake blockade
D) Irreversible MAO-A inhibition
E) NMDA receptor blockade

Q28. A patient with major depression and CHRONIC NEUROPATHIC PAIN would BEST be treated with which antidepressant class (dual benefit - depression + pain)?

A) SSRIs
B) MAOIs
C) SNRIs (e.g., duloxetine, venlafaxine)
D) Bupropion
E) Mirtazapine

Q29. Which antidepressant is CONTRAINDICATED with tramadol AND meperidine (as highlighted in the Katzung case study) due to risk of fatal serotonin syndrome?

A) Bupropion
B) Mirtazapine
C) SSRIs/SNRIs and MAOIs
D) TCAs only
E) Trazodone

Q30. Venlafaxine at LOW doses primarily inhibits which transporter, while at HIGHER doses also significantly inhibits NE reuptake?

A) Dopamine transporter (DAT) only
B) Serotonin transporter (SERT) primarily; NE transporter (NET) added at higher doses
C) NE transporter only
D) Both SERT and NET equally at all doses
E) MAO-A and MAO-B

✅ ANSWER KEY + EXPLANATIONS

A1. C - D2 blockade in the nigrostriatal pathway causes EPS (parkinsonism). This is the same pathway involved in voluntary movement. (Lippincott Ch. 18)

A2. C - Chlorpromazine is the classic low-potency typical antipsychotic. Low-potency agents bind more loosely to D2 but strongly to histamine and alpha-1 receptors, causing sedation and orthostasis rather than EPS. (Lippincott)

A3. B - Agranulocytosis (1-2% risk) is clozapine's most feared complication. Mandatory REMS program requires ANC monitoring. (Lippincott Ch. 18)

A4. D - Neuroleptic malignant syndrome (NMS): the tetrad is hyperthermia, "lead-pipe" rigidity, altered consciousness, and autonomic instability. Elevated CK is hallmark. Treatment: stop antipsychotic, dantrolene, bromocriptine. (Katzung)

A5. D - Aripiprazole is a dopamine-serotonin system stabilizer: partial D2 agonist + partial 5-HT1A agonist + 5-HT2A antagonist. Hence lower risk of EPS and hyperprolactinemia. (Lippincott)

A6. B - Mesolimbic pathway hyperdopaminergic activity drives positive symptoms. (Lippincott Ch. 18)

A7. D - Tuberoinfundibular pathway: dopamine normally inhibits prolactin release. Block it → hyperprolactinemia → galactorrhea/amenorrhea. (Lippincott)

A8. D - Olanzapine has the highest metabolic liability among atypicals. Clozapine is comparable. Aripiprazole and ziprasidone are metabolically neutral. (Katzung)

A9. C - Tardive dyskinesia: late-onset, persistent, choreiform movements of face/tongue after prolonged D2 blockade. Treatment: reduce/stop antipsychotic; valbenazine/deutetrabenazine. (Lippincott)

A10. C - Pimavanserin is a selective 5-HT2A/2C inverse agonist with NO D2 activity, so it controls psychosis in PD without worsening parkinsonism. (Lippincott)

A11. B - Benzodiazepines bind an allosteric site on GABA-A, increasing frequency of Cl⁻ channel opening (barbiturates increase duration). (Lippincott Ch. 16)

A12. D - Lorazepam (and oxazepam, temazepam - the "LOT" drugs) undergo glucuronidation only - safe in liver disease, elderly, and neonates. (Lippincott)

A13. B - Flumazenil is a competitive antagonist at the benzodiazepine binding site on GABA-A. Short acting (~1 hr) - re-sedation can occur. (Lippincott)

A14. D - Buspirone is a 5-HT1A partial agonist. No sedation, no abuse potential, no withdrawal, no potentiation of CNS depressants. BUT: takes 2-4 weeks to work (not PRN). (Lippincott Ch. 16)

A15. B - Barbiturates increase duration of Cl⁻ channel opening (vs. benzodiazepines which increase frequency). Barbiturates have a LOW therapeutic index (not reversed by flumazenil). (Lippincott)

A16. D - Diazepam (t½ ~20-100 hrs) with active metabolites (desmethyldiazepam) lasting days - used for alcohol withdrawal but accumulates in elderly. (Katzung/Lippincott)

A17. B - Abrupt benzodiazepine withdrawal after prolonged use causes rebound anxiety, insomnia, tremors, and potentially life-threatening seizures. Taper slowly. (Lippincott)

A18. C - SSRIs/SNRIs are first-line for GAD, PTSD, OCD, and panic disorder. Lippincott explicitly notes these are covered in the antidepressant chapter. (Lippincott Ch. 16)

A19. B - The biogenic amine theory: depression = deficiency of norepinephrine and/or serotonin. Note: this is overly simplistic (doesn't explain why effects are delayed weeks). (Lippincott Ch. 17)

A20. C - Fluoxetine has norfluoxetine (active metabolite) with t½ of 1-2 weeks, making it the most forgiving SSRI for missed doses and safest to switch from without washout concerns. (Katzung)

A21. B - Fluoxetine (SSRI) + tramadol (serotonergic + opioid) = serotonin syndrome risk: agitation, hyperthermia, clonus, diaphoresis. (Katzung case study)

A22. B - TCAs block reuptake of norepinephrine AND serotonin. They also block muscarinic, H1, and alpha-1 receptors (explaining many side effects). (Lippincott)

A23. C - TCA overdose triad: cardiac arrhythmia (wide QRS, QT prolongation), CNS depression/seizures, and anticholinergic effects (dry mouth, urinary retention, delirium). Treat with IV sodium bicarbonate. (Katzung)

A24. C - Hypertensive crisis: MAOIs block MAO in gut/liver that normally breaks down tyramine. Tyramine enters circulation, causes massive NE release → severe hypertension. (Katzung/Lippincott)

A25. B - At low doses, selegiline selectively inhibits MAO-B (which metabolizes dopamine preferentially). At high doses it loses selectivity. (Lippincott)

A26. C - Bupropion is an NDRI (norepinephrine-dopamine reuptake inhibitor). It does NOT cause sexual dysfunction or weight gain, and lowers the seizure threshold. (Lippincott Ch. 17)

A27. B - Mirtazapine blocks presynaptic alpha-2 autoreceptors (increases NE/5-HT release) and postsynaptic 5-HT2/5-HT3. The H1 blockade causes weight gain and sedation - useful in depressed patients with insomnia/poor appetite. (Lippincott/Katzung)

A28. C - SNRIs (duloxetine especially) are FDA-approved for both MDD and chronic neuropathic/musculoskeletal pain. (Katzung Ch. 30)

A29. C - The Katzung case specifically highlights that MAOIs are contraindicated with tramadol and meperidine (fatal serotonin syndrome risk). SSRIs combined with tramadol/meperidine also carry serotonin syndrome risk. (Katzung)

A30. B - Venlafaxine at low doses acts mainly as an SSRI; at higher doses (>150 mg) it also significantly inhibits the NE transporter (NET), making it a full SNRI. (Katzung Ch. 30)

📊 Score Yourself

Score	Grade
27-30	Excellent - Exam ready!
23-26	Good - Review weak spots
18-22	Average - Re-read key chapters
<18	Needs revision - Focus on mechanisms

All questions sourced from Lippincott Illustrated Reviews Pharmacology & Katzung's Basic and Clinical Pharmacology, 16th Ed. Reply with your answers if you'd like me to score you and explain any wrong answer in detail!

This is a shared conversation. Sign in to Orris to start your own chat.